UNSPSC 51142309: Levallorphan tartrate

This classification denotes an opiate antagonist with the molecular formula C19H25NO.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U0VSF7HTN0, chemically known as 2h-10,4a-iminoethanophenanthren-6-ol, 11-allyl-1,3,4,9,10,10a-hexahydro-, tartrate but more generally known as levallorphan tartrate, which bears US NIH Compound Identifier 5464111. European Medicines Agency schedules Levallorphan tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02901MIG.

UNSPSC 51142309 Levallorphan tartrate is a Commodity code, but the recent state and local procurement activity tagged under it does not align with the code's pharmaceutical scope. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually — neither of which matches levallorphan tartrate. The source shows no other recent state and local solicitations under this code.

The mismatch between the code's intended commodity and the actual procurement posted suggests that either the county applied an incorrect UNSPSC classification or that state and local procurement activity under 51142309 remains minimal. The Seminole County opportunity centers on naloxone (a distinct opioid antagonist) and drug deactivation equipment for community health delivery, with quarterly shipments to the Seminole County Community Health Building in Sanford, Florida, and contract terms of two years plus a one-year renewal option. Bidders must comply with E-Verify, drug-free workplace certification, and maintain commercial general liability, workers' compensation, and professional liability insurance. Without additional recent opportunities under this code from other jurisdictions, the data do not support a reliable characterization of state and local buying patterns under 51142309 levallorphan tartrate.